SCHEMBL28536202

SCHEMBL28536202

CCOc1c[nH]cc1-c1ccc2c(c1)NCC2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ S1PR1 P21453 4/20 0.53
▸ JAK2 O60674 2/20 0.45
▸ JAK3 P52333 2/20 0.45
▸ S1PR3 Q99500 2/20 0.42
▸ ABCC4 O15439 1/20 0.41
▸ ABCB11 O95342 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ ADRA2A P08913 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41
▸ CHRM1 P11229 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ PDE4A P27815 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CDK9 P50750 1/20 0.37
▸ SYK P43405 3/20 0.36
▸ AURKB Q96GD4 2/20 0.36
▸ INCENP Q9NQS7 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21747952 0.77 JAK2 (0.52) S1PR1JAK2JAK3S1PR3CDK9
SCHEMBL15880148 0.72 HRH3 (0.48) S1PR1JAK2JAK3SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL1426687 0.71 HRH3 (0.47) S1PR1JAK2JAK3SMN1; SMN2MAPT
SCHEMBL17785717 0.70 JAK2 (0.41) S1PR1JAK2JAK3SMN1; SMN2CDK9
SCHEMBL10922053 0.70 CHEK1 (0.50) HTR2CALDH1A1
SCHEMBL13416834 0.69 S1PR1 (1.00) S1PR1S1PR3SMN1; SMN2MAPTALDH1A1
SCHEMBL21760537 0.68 S1PR1 (0.49) S1PR1JAK2JAK3S1PR3ABCC4
SCHEMBL10926032 0.68 TDP2 (0.53) S1PR1SYKAURKBINCENPHTR2C
SCHEMBL27993444 0.67 CD274 (0.51) SMN1; SMN2MAPTGAAALDH1A1KDM4E
SCHEMBL23019983 0.67 S1PR1 (0.55) S1PR1JAK2JAK3S1PR3ABCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112585138-A 4-substituted pyrrolo [2,3-b ] pyridines as ErbB modulators useful in the treatment of cancer 利德探索中心有限公司 2021-03-30 — — CN disclosed
Send feedback